Sherbrooke Park Advisers LLC Vericel Corp Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Vericel Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 5,215 shares of VCEL stock, worth $221,846. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,215Holding current value
$221,846% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
52.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$343 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$149 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$123 Million3.98% of portfolio
-
State Street Corp Boston, MA2.44MShares$104 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.27MShares$96.7 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.01B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...